Assistance Publique Hôpitaux de Paris, Hôpital Louis Mourier, Service de Réanimation Médicale and 2 Service de Bactériologie, Colombes; 3
|
|
- Wilfrid Cain
- 6 years ago
- Views:
Transcription
1 MAJOR ARTICLE Levels of Vancomycin in Cerebrospinal Fluid of Adult Patients Receiving Adjunctive Corticosteroids to Treat Pneumococcal Meningitis: A Prospective Multicenter Observational Study Jean-Damien Ricard, 1,3 Michel Wolff, 4 Jean-Claude Lacherade, 5 Bruno Mourvillier, 6 Nadia Hidri, 2 Guilène Barnaud, 2 Guillaume Chevrel, 1 Lila Bouadma, 4 and Didier Dreyfuss 1 1 Assistance Publique Hôpitaux de Paris, Hôpital Louis Mourier, Service de Réanimation Médicale and 2 Service de Bactériologie, Colombes; 3 INSERM (Instiut National de la Santé et de la Recherche Médicale), U722, UFR (Unité de Formation et de Recherche) de Médecine Paris 7 Denis Diderot, Site Bichat, and 4 Assistance Publique Hôpitaux de Paris, Hôpital Bichat, Service de Réanimation Médicale et Infectieuse, Paris; 5 Service de Réanimation, Centre Hospitalier Poissy-St-Germain, Poissy; and 6 Service de Réanimation, Centre Hospitalier d Aulnay, Aulnay, France Background. Evidence from a recent randomized controlled trial suggests that dexamethasone as adjunct therapy in adult pneumococcal meningitis reduces mortality and neurological sequelae. However, adding dexamethasone has the potential to reduce penetration of vancomycin into the cerebrospinal fluid (CSF). We sought to determine concentrations of vancomycin in serum and CSF of patients with suspected or proven pneumococcal meningitis receiving dexamethasone to assess the penetration of vancomycin into the CSF during steroid therapy. Methods. In an observational open multicenter study, adult patients admitted to the intensive care unit because of suspected pneumococcal meningitis received recommended treatment for pneumococcal meningitis, comprising intravenous cefotaxime (200 mg per kg of body weight per day), vancomycin (administered as continuous infusion of 60 mg per kg of body weight per day after a loading dose of 15 mg per kg of body weight), and adjunctive therapy with dexamethasone (10 mg every 6 h). Vancomycin levels in CSF were measured on day 2 or day 3 of therapy and were correlated with protein levels in CSF and vancomycin levels in serum (determined at the same time as levels in CSF). Results. Fourteen patients were included. Thirteen had proven pneumococcal meningitis; 1 patient, initially suspected of having pneumococcal meningitis, was finally determined to have meningitis due to Neisseria meningitidis. Mean levels of vancomycin in serum and CSF were 25.2 and 7.2 mg/l, respectively, and were positively correlated ( r p 0.6; P p.025). A positive correlation was also found between the ratio of vancomycin in CSF to vancomycin in serum and the level of protein in CSF ( r p 0.66; P p.01). Conclusions. Appropriate concentrations of vancomycin in CSF may be obtained even when concomitant steroids are used. Dexamethasone can, therefore, be used without fear of impeding vancomycin penetration into the CSF of patients with pneumococcal meningitis, provided that vancomycin dosage is adequate. This study is registered at (registration number NCT ). Streptococcus pneumoniae is the pathogen most commonly isolated from adults with community-acquired meningitis and is responsible for a high rate of deaths and/or neurological sequelae [1 5]. With the dramatic Received 4 July 2006; accepted 19 September 2006; electronically published 15 December Reprints or correspondence: Dr. Didier Dreyfuss, Service de Réanimation Médicale, Hôpital Louis Mourier, Colombes, France (didier.dreyfuss@lmr.ap-hp.fr). Clinical Infectious Diseases 2007;44: by the Infectious Diseases Society of America. All rights reserved /2007/ $15.00 increase in the prevalence of strains that are nonsusceptible to penicillin G, combination therapy with either cefotaxime or ceftriaxone and vancomycin has become the standard empirical antimicrobial therapy. Conceivably, meningitis due to penicillin-nonsusceptible S. pneumoniae might constitute a risk factor for severe prognosis [6], given the limited penetration of many antibiotics (including third-generation cephalosporins) into CSF, even when meningeal inflammation is present [7, 8]. However, penetration of vancomycin into the CSF is far from optimal [7, 9, 10], and the 250 CID 2007:44 (15 January) Ricard et al.
2 vancomycin MIC for S. pneumoniae usually ranges between 0.25 and 1 mg/ml [7, 9, 10], which may lead to poorly bactericidal titers in CSF [7, 9]. Moreover, on the basis of the available evidence on the use of adjunctive dexamethasone treatment in adults, especially from a recent controlled study [11], this drug is now recommended for adults with suspected or proven pneumococcal meningitis (10 mg 4 times daily for 4 days). However, because CSF penetration by hydrophilic antibiotics, such as b-lactams or vancomycin, is strongly influenced by meningeal inflammation [7, 8, 10, 12], concerns have been raised about the possible deleterious effect of high-dose steroids. In fact, the presence of a nonsusceptible strain, combined with insufficient levels of vancomycin in CSF, could delay sterilization of CSF, with negative consequences for clinical outcome. The only large randomized trial that clearly demonstrated an improved prognosis after corticosteroid treatment in adults was conducted among patients who were treated with a b-lactam antibiotic alone, usually amoxicillin [11]. In this study [11], all strains that underwent in vitro susceptibility testing (72% of the total) displayed normal susceptibility to penicillin, but it cannot be excluded that some of the other strains may have been resistant to penicillin. The purpose of this prospective clinical study was to demonstrate that acceptable concentrations of vancomycin may be achieved in the CSF of patients with pneumococcal meningitis treated with dexamethasone, provided high serum levels are obtained as the result of adequate intravenous dosing. METHODS This prospective study was performed in 4 medical intensive care units of 4 Paris-area hospitals. All consecutive patients 118 years of age who were hospitalized in the participating intensive care units were included, provided that they had proven or suspected pneumococcal meningitis and that a second lumbar puncture was performed on day 2 or day 3 to assess favorable evolution of meningitis. Pneumococcal meningitis was defined as CSF pleocytosis (110 cells/ml) and one or more of the following criteria: a positive result of culture of CSF or blood; gram-positive diplococci in a direct smear examination of the CSF; or presence of pneumococcal antigens in the CSF detected by a latex agglutination method. The treatment followed recommendations of the Consensus Conference organized by the French Society of Infectious Diseases [13]. The antibiotic regimen comprised the administration of intravenous cefotaxime (200 mg per kg of body weight per day in 4 divided doses) and intravenous vancomycin (continuous infusion of 60 mg per kg of body weight per day after a loading dose of 15 mg per kg of body weight), pending susceptibility results. Dexamethasone (10 mg every 6 h) was administered intravenously for 4 days, with the first dose given just before or concomitant with the first dose of antimicrobial therapy, according to the methods of de Gans and van de Beek [11]. In addition, patients treated in one of the centers received intravenous rifampin at a dose of 20 mg per kg of body weight per day, as recently suggested [14, 15]. As soon as b-lactam susceptibility results were available, vancomycin (and rifampin) therapy was stopped for patients infected with organisms susceptible to cefotaxime. On day 2 or day 3 after the start of antimicrobial therapy, serum and CSF samples were obtained simultaneously, and vancomycin concentrations were determined using the fluorescent polarization immunoassay [16]. The susceptibility of S. pneumoniae isolates to b-lactam agents and vancomycin was determined for all patients from whom this organism was obtained by culture (12 patients). A 1-mg oxacillin disk was used to identify penicillin-resistant strains. Penicillin G, amoxicillin, and cefotaxime MICs were determined in each hospital laboratory with use of Etest. Vancomycin MICs were determined for 10 patients. Susceptibility categories were assigned according to the 1997 Clinical and Laboratory Standards Institute (then the National Committee for Clinical Laboratory Standards) guidelines for break points [17], as follows: for penicillin G, 0.06 mg/l was susceptible, mg/l was intermediate, and 2 mg/l was resistant; for amoxicillin and cefotaxime, 0.5 mg/l was susceptible, 1 mg/l was intermediate, and 2 mg/l was resistant; for vancomycin, 1 mg/l was susceptible. Usual demographic data were collected, including age, weight, simplified acute physiology score II [18], Glasgow coma score, receipt of mechanical ventilation, and outcome. Data are presented as mean value ( SD). Correlations were calculated with GraphPad Prism 3 statistical software (Graph- Pad Software). P!.05 was considered to be statistically significant. The study protocol was approved by the Ethical Committee of the French Intensive Care Society. Because the protocol consisted only in the prospective collection of data that were requested for patient care, and because no additional investigational or treatment procedure was requested, formal patient consent was not required, but all procedures and their purposes were explained to the patient or to a proxy in the case of patient incompetence. This study is registered at http: // (registration number NCT ). RESULTS Fourteen patients were included in the study. The mean age ( SD) was years (range, years); 8 patients were male, and 6 patients were female. The mean simplified acute physiology score II ( SD) was 43 20, and the mean Glasgow coma score ( SD) was 7 3. Ten (71%) of 14 patients required mechanical ventilation. All patients had CSF characteristics that Vancomycin in CSF with Dexamethasone CID 2007:44 (15 January) 251
3 Table 1. Characteristics of CSF samples obtained from patients with pneumococcal meningitis. Characteristic First lumbar puncture Second lumbar puncture Leukocyte count, cells/ml Protein level, g/l Glucose level, mmol/l Gram-positive cocci on direct examination of CSF, no. of patients 13 a 7 Positive results of CSF culture for Streptococcus pneumoniae, no. of patients 12 a 0 Positive results for soluble S. pneumoniae antigens in CSF, no. of patients 8 ND Penicillin-nonsusceptible S. pneumoniae isolates, proportion (%) of isolates 7/12 (58) NOTE. Data are mean value ( SD), unless otherwise indicated. ND, not done. a One sample finally yielded Neisseria meningitidis, and 1 sample was sterile, but direct examination yielded findings positive for gram-positive cocci and for soluble S. pneumoniae antigens. strongly suggested the diagnosis of bacterial meningitis (table 1): pleocytosis was marked, glucose concentrations were very low (mean value,!0.5 g/l), and protein concentrations were very high (15 g/l in 10 patients, with 4 patients exhibiting a protein concentration of 110 g/l). The maximum protein concentration was 24 g/l, and the lowest protein concentration was 0.81 g/l (in a patient with severe serum hypoproteinemia). Thirteen of the 14 patients had confirmed pneumococcal meningitis: in 12 patients, direct examination of CSF yielded results positive for gram-positive cocci, and culture results were positive for S. pneumoniae; in 1 patient, direct examination of CSF yielded positive results for gram-positive cocci, with positive results of S. pneumoniae antigen detection, but culture of CSF did not yield S. pneumoniae. The final patient was initially incorrectly given the diagnosis of pneumococcal meningitis on the basis of a false-positive result of direct smear staining of a CSF sample. Culture (after a follow-up lumbar puncture was performed) eventually yielded a slow growth of Neisseria meningitidis (table 1). Blood culture results were positive for S. pneumoniae in 8 patients. Susceptibility to b-lactam antibiotics was determined for 12 of 13 pneumococcal isolates available by culture (as mentioned above, CSF samples were sterile in 1 case, but direct examination showed gram-positive cocci, and soluble S. pneumoniae antigens were detected). Seven of the 12 pneumococcal strains were not susceptible to penicillin. One of these 7 isolates was determined to have intermediate susceptibility to amoxicillin and cefotaxime (MIC, 1.5 mg/l). No organism displayed MIC Table 2. outcome. Vancomycin concentrations in serum and CSF samples, corresponding vancomycin MICs, and Patient Vancomycin concentration Serum, mg/l CSF, mg/l Vancomycin MIC, mg/l Outcome Died, irreversible coma Survived Survived Survived Survived with neurological sequelae Survived Died, septic shock Survived NP a Survived Survived NP b Survived, with neurological sequelae Survived Died, irreversible coma Survived All, mean value SD NOTE. NP, not possible. a CSF eventually yielded Neisseria meningitis. b CSF was sterile but direct examination yielded findings positive for gram-positive cocci and CSF was positive for soluble Streptococcus pneumonia antigens. 252 CID 2007:44 (15 January) Ricard et al.
4 concentration of protein and the ratio of vancomycin concentration in CSF to the same values for serum (figure 2). The outlier, with a very low protein concentration in CSF samples, corresponded to a severely malnourished patient with a very low protein concentration in plasma samples. Mean blood urea and creatinine concentrations were 6.2 mmol/l and 84.4 mmol/ L, respectively (excluding 1 patient undergoing chronic renal replacement). DISCUSSION Figure 1. Correlation between levels of vancomycin in serum and CSF in patients with meningitis. The bold arrow indicates the patient who was eventually determined to have meningitis due to Neisseria meningitidis. 2 mg/l. All strains were susceptible to vancomycin. In the 10 patients for whom it was determined, the vancomycin MIC for S. pneumoniae was mg/l (table 2). All patients received the protocol-recommended antibiotic regimen, consisting of cefotaxime and vancomycin. Six patients received intravenous rifampin in addition (see Methods). In 1 patient, who had severe chronic renal insufficiency, dosages of cefotaxime and vancomycin were adapted according to renal function. A second lumbar puncture was performed on day 2 for 4 patients and on day 3 for 10 patients. Characteristics of CSF samples obtained during the second lumbar puncture are shown in table 1. There was a marked improvement in all parameters, with pronounced decreases in protein concentrations and increases in glucose levels. Bacterial culture results were negative for all patients. The antibiotic regimens were adapted according to antibacterial susceptibility results (i.e., discontinuation of vancomycin and of rifampin when added except for the patient with isolates with intermediate susceptibility to cefotaxime). Three patients died (2 of irreversible coma and 1 of concomitant pneumococcal septic shock). Two other patients were discharged from the intensive care unit with severe neurological sequelae, and the 9 remaining patients resumed normal neurological status and were discharged from the hospital. The mean concentration of vancomycin in serum samples was 25.2 mg/l (range, mg/l). The mean concomitant concentration of vancomycin in CSF samples was 7.9 mg/l (range, mg/l). Table 2 shows individual and mean values for vancomycin concentrations. A significant correlation was found between vancomycin concentrations in serum and CSF samples ( r p.68; P p.01) (figure 1). This correlation re- mained unchanged when the patient, who was finally determined to have meningococcal meningitis, was excluded from the study. There was also a significant correlation between the To the best of our knowledge, this is the first clinical study evaluating the role of high-dose systemic vancomycin administration in the achievement of adequate CSF levels of this antibiotic in patients receiving adjunctive dexamethasone treatment for bacterial meningitis. Acceptable levels of vancomycin were obtained in CSF samples obtained from all of our patients: none had!3.1 mg/l, and the mean value was 7.9 mg/l (or 30% of the simultaneously determined concentration in serum samples). All pneumococcal isolates in our study were susceptible to vancomycin, and MICs were in the range of published data [9, 10]. As a result, the concentration of vancomycin in CSF was at least 10-fold the MIC in 8 patients, 8-fold the MIC in 2 patients, and 4-fold the MIC in 1 patient (table 2). These high doses may be needed to achieve acceptable bactericidal titers in CSF. More importantly, penetration of vancomycin into CSF was found to be linearly correlated with the concentration of vancomycin in serum. This correlation was not altered when the patient who was finally given the diagnosis of meningococcal meningitis was excluded. We chose to retain this patient in the analysis, because he received exactly the same initial treatment Figure 2. Correlation between the concentration of protein in CSF (an indicator of blood-brain barrier permeability) and the ratio of vancomycin concentration in CSF to vancomycin concentration in serum. Positive correlation confirms that meningeal permeability, partly induced by meningeal inflammation, affects the rate of vancomycin penetration into the CSF. The bold arrow indicates the patient with severe hypoproteinemia. Vancomycin in CSF with Dexamethasone CID 2007:44 (15 January) 253
5 Figure 3. Mean levels of vancomycin in CSF, compared with mean levels of vancomycin in serum, in experimental and clinical studies of pneumococcal meningitis. Only those studies that explicitly reported concomitant serum and CSF levels of vancomycin were included. Seven studies, including the present study, were identified. Experimental studies sometimes compared conditions with and without dexamethasone, thus providing a total of 12 data points. There was a strong positive correlation between serum and CSF levels of vancomycin. Open circles, clinical studies that used dexamethasone [9], including our study (arrow); open squares, experimental studies with dexamethasone [21, 23, 27]; solid circles, clinical studies in which treatment did not include use of dexamethasone [25, 26]; solid squares, experimental studies without dexamethasone [23, 27]. as the other patients. Our findings suggest that adequate (and possibly high) therapeutic concentrations may be achieved in the CSF, provided that adequate monitoring of serum level and subsequent adaptation of the administered dose are implemented. Levels of vancomycin in serum during continuous infusion in our study were probably higher than the trough levels of mg/l that are recommended in the practice guidelines for the management of bacterial meningitis recently issued by the Infectious Diseases Society of America [15]. However, these recommendations suggest the use of vancomycin at a dosage of mg per kg of body weight per day in adults, whereas we conformed to the recommendations of the French Society of Infectious Diseases [13] to administer vancomycin at a dosage of 60 mg per kg of body weight per day either in 4 divided doses (the same therapeutic regimen that was suggested by the Committee on Infectious Diseases of the American Academy of Pediatrics [19]) or as a continuous infusion (preceded by a 15-mg per kg of body weight loading dose). These high dosages may be needed to achieve acceptable bactericidal titers in CSF. Indeed, concentrations in CSF were 13 mg/l in our 14 patients (mean level, 7.9 mg/l). This must be put into perspective with findings in a study by Viladrich et al. [9], who failed to detect vancomycin in the CSF of 3 patients and found a level of!2 mg/l in another 8 patients treated with vancomycin administered at a dosage of 7.5 mg per kg of body weight 3 times daily, whereas 3 patients who received higher dosages (15 mg per kg of body weight 3 times daily) had vancomycin levels in CSF of mg/l. A continuous-administration schedule with a loading dose was used because we previously demonstrated that targeted serum levels were obtained more rapidly with continuous than with intermittent administration of vancomycin [20]. There is, however, no reason to think that results would be markedly different if intermittent administration was used, as recommended in the United States. As expected, we found that vancomycin penetration into the CSF was correlated with protein levels in CSF, which is a marker of blood-brain barrier permeability caused by meningeal inflammation. The anti-inflammatory effects of corticosteroids on vancomycin penetration into the CSF are debated. Dexamethasone reduced the penetration of vancomycin into CSF by 20% 30% during experimental studies of pneumococcal meningitis [21 24]. Data in humans are conflicting: children receiving adjunctive steroids had acceptable levels of vancomycin in CSF during pneumococcal meningitis [25], whereas vancomycin levels were low or even undetectable in CSF samples obtained from adults with pneumococcal meningitis [9]. Our results suggest that the possible impairment of vancomycin penetration into CSF could be overcome by increasing the dosage of vancomycin, as previously suggested [23]. Moreover, serum and CSF concentrations of vancomycin were very close to those previously reported for patients receiving similar high dosages for the treatment of postneurosurgical meningitis and who were not treated with dexamethasone [26]. This observation prompted us to plot vancomycin concentrations in serum and CSF measured in various conditions (experimental or clinical and with or without corticosteroids) on the same graph. We identified 6 studies [9, 21, 23, 25 27] that reported both serum and CSF levels of vancomycin. Thus, including our own results, 12 sets of paired serum and CSF vancomycin concentrations were plotted (figure 3). We were surprised to observe a highly significant linear relationship, with a very high slope (0.32) that was not significantly different from the slope observed in this study (0.42). Taken together, these observations strongly suggest that appropriate vancomycin levels may be obtained in the CSF of patients treated with adjunctive corticosteroids, provided that high serum levels are obtained through the use of a high, continuous, intravenous dose, preceded by a loading dose. Given the narrow therapeutic margin of vancomycin, one may wonder whether high serum levels may prove toxic. Obviously, this is to be put in balance with the risk of undertreating a deadly disease. In fact, serum vancomycin concentrations of up to 30 mg/l, as observed in this study, may remain in a relatively safe range, especially in the light of the brevity of treatment if the offending pathogen does not display high-level resistance to third-generation cephalosporins, allowing treatment to be tapered. Although drug toxicity may be difficult to ascertain or 254 CID 2007:44 (15 January) Ricard et al.
6 rule out in critically ill patients, this high-dosage regimen seemed to be well tolerated by our patients: no skin rash or unexplained hemodynamic instability were observed, and there was no alteration of renal function that could be specifically related to the treatment regimen. Our study was a pragmatic one that consisted of the evaluation of recent recommendations for treatment of these patients [15]. Indeed, it may be very difficult, if not impossible, to conduct a randomized, controlled study on this subject [28]. Acknowledgments This article is dedicated to the memory of Dr. Arnaud de Lassence. Potential conflicts of interest. All authors: no conflicts. References 1. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993; 328: Auburtin M, Porcher R, Bruneel F, et al. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med 2002; 165: Swartz MN. Bacterial meningitis: a view of the past 90 years. N Engl J Med 2004; 351: van de Beek D, Schmand B, de Gans J, et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002; 186: van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin non susceptible strains in ICU adults with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006; 34: Lutsar I, McCracken GH Jr, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998; 27: , quiz Kearney BP, Aweeka FT. The penetration of anti-infectives into the central nervous system. Neurol Clin 1999; 17: Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991; 35: Kucers A, Crowe S, Grayson M, Hoy J. The use of antibiotics. Oxford, UK: Butterworth-Heinemann, de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: Schaad UB, Nelson JD, McCracken GH Jr. Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis 1981; 3(suppl):S ème conférence de consensus en thérapeutique anti-infectieuse: les méningites purulentes communautaires. Med Mal Infect 1996; 26: Tan TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Curr Opin Infect Dis 2003; 16: Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39: Filburn BH, Shull VH, Tempera YM, Dick JD. Evaluation of an automated fluorescence polarization immunoassay for vancomycin. Antimicrob Agents Chemother 1983; 24: National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria date grown aerobically: approved standard. 4th ed. Document M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1997; 99: Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001; 45: Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH Jr. Effect of dexamethasone on therapy of experimental penicillinand cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994; 38: Cabellos C, Martinez-Lacasa J, Martos A, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995; 39: Ahmed A, Jafri H, Lutsar I, et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1999; 43: Martinez-Lacasa J, Cabellos C, Martos A, et al. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Chemother 2002; 49: Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39: Albanese J, Leone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 2000; 44: Lee H, Song JH, Kim SW, et al. Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis. Int J Antimicrob Agents 2004; 23: Tunkel AR, Scheld WM. Corticosteroids for everyone with meningitis? N Engl J Med 2002; 347: Vancomycin in CSF with Dexamethasone CID 2007:44 (15 January) 255
by author ESCMID Online Lecture Library Steroids in acute bacterial meningitis
Steroids in acute bacterial meningitis Javier Garau, MD, PhD University of Barcelona Spain ESCMID Summer School, Porto, July 2009 Dexamethasone treatment in childhood bacterial meningitis in Malawi: a
More informationEvaluation of Vancomycin Continuous Infusion in Trauma Patients
OBJECTIVES Evaluation of Vancomycin Continuous Infusion in Trauma Patients Brittany D. Bissell, Pharm.D. PGY-2 Critical Care Pharmacy Resident Jackson Memorial Hospital Miami, Florida Evaluate the potential
More informationSteroid Therapy for Bacterial Meningitis
685 REVIEW ARTICLE Steroid Therapy for Bacterial Meningitis Urs B. Schaad, Sheldon L. Kaplan, and George H. McCracken, Jr. Front the Departments of Pediatrics, University of Basel, Basel, Switzerland;
More informationBacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B.
UvA-DARE (Digital Academic Repository) Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. Link to publication Citation for published version (APA): Heckenberg,
More informationICU Volume 11 - Issue 3 - Autumn Series
ICU Volume 11 - Issue 3 - Autumn 2011 - Series Impact of Pharmacokinetics of Antibiotics in ICU Clinical Practice Introduction The efficacy of a drug is mainly dependent on its ability to achieve an effective
More informationAJRCCM Articles. Published on February 23, 2012
Fever Control Using External Cooling in Septic Shock: A Randomized Controlled Trial Frédérique Schortgen, Karine Clabault, Sandrine Katsahian, Jerome Devaquet, Alain Mercat, Nicolas Deye, Jean Dellamonica,
More informationORIGINAL ARTICLE /j x. Barcelona, Spain
ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01839.x Community-acquired bacterial meningitis in cirrhotic patients C. Cabellos 1, P. F. Viladrich 1, J. Ariza 1, J.-M. Maiques 1, R. Verdaguer 2 and F. Gudiol
More informationGUIDELINE FOR THE MANAGEMENT OF MENINGITIS. All children with suspected or confirmed meningitis
GUIDELINE FOR THE MANAGEMENT OF MENINGITIS Reference: Mennigitis Version No: 1 Applicable to All children with suspected or confirmed meningitis Classification of document: Area for Circulation: Author:
More informationAssociation Between Vancomycin Blood Brain Barrier Penetration and Clinical Response in Postsurgical Meningitis
Association Between Vancomycin Blood Brain Barrier Penetration and Clinical Response in Postsurgical Meningitis Qing Wang 1, Si Chen 2, Yan-Gang Zhou 1, Ping Xu 1, Yi-Ping Liu 1, Hua-Lin Cai 1, Hong Chen
More informationTherapeutic drug monitoring of β-lactams
CORATA Belgique Reims 1-2/10/2014 Therapeutic drug monitoring of β-lactams Frédéric Cotton Clinical Chemistry Erasme Hospital Faculty of Pharmacy ULB TDM of β-lactams β-lactams pharmacokinetics pharmacodynamics
More informationCerebral vasculitis complicating postoperative meningitis: the role of steroids revisited
Published 29 October 2012, doi:10.4414/smw.2012.13697 Cite this as: Cerebral vasculitis complicating postoperative meningitis: the role of steroids revisited Katharine E. A. Darling a, Julien Niederhauser
More informationAseptic meningitis with CSF persistence of pneumococcal cell wall components after ACCEPTED
JCM Accepts, published online ahead of print on September 00 J. Clin. Microbiol. doi:./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationResponse of Vancomycin according to Steroid Dosage in Pediatric Patients with Culture-Proven Bacterial Meningitis
Original Article https://doi.org/0.3947/ic.207.49.4.262 Infect Chemother 207;49(4):262-267 ISSN 2093-2340 (Print) ISSN 2092-6448 (Online) Infection & Chemotherapy Response of according to Steroid Dosage
More informationThe Diagnostic Accuracy of Kernig s Sign, Brudzinski s Sign, and Nuchal Rigidity in Adults with Suspected Meningitis
MAJOR ARTICLE The Diagnostic Accuracy of Kernig s Sign, Brudzinski s Sign, and Nuchal Rigidity in Adults with Suspected Meningitis Karen E. Thomas, 1 Rodrigo Hasbun, 1 James Jekel, 2 and Vincent J. Quagliarello
More informationPractice Guidelines for the Management of Bacterial Meningitis
IDSA GUIDELINES Practice Guidelines for the Management of Bacterial Meningitis Allan R. Tunkel, 1 Barry J. Hartman, 2 Sheldon L. Kaplan, 3 Bruce A. Kaufman, 4 Karen L. Roos, 5 W. Michael Scheld, 6 and
More informationPharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of
Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of Cefoperazone Sulbactam Singh M*, Kochhar P* Medical & Research Division, Pfizer India. Summary Antimicrobial resistance is associated with
More informationANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS
ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS Version 4.0 Date ratified February 2009 Review date February 2011 Ratified by Authors Consultation Evidence
More informationAMERICAN ACADEMY OF PEDIATRICS. Therapy for Children With Invasive Pneumococcal Infections
AMERICAN ACADEMY OF PEDIATRICS Committee on Infectious Diseases Therapy for Children With Invasive Pneumococcal Infections ABSTRACT. This statement provides guidelines for therapy of children with serious
More informationFever Interval before Diagnosis, Prior Antibiotic Treatment, and Clinical Outcome for Young Children with Bacterial Meningitis
MAJOR ARTICLE Fever Interval before Diagnosis, Prior Antibiotic Treatment, and Clinical Outcome for Young Children with Bacterial Meningitis Bema K. Bonsu 1 and Marvin B. Harper 2 1 Department of Medicine,
More informationClinical features and prognostic factors in childhood pneumococcal meningitis
J Microbiol Immunol Infect. 2008;41:48-53 Original Article Clinical features and prognostic factors in childhood pneumococcal meningitis Yen-Nan Chao, Nan-Chang Chiu, Fu-Yuan Huang Department of Pediatrics,
More informationInitiation Strategies for Renal Replacement Therapy in ICU
Initiation Strategies for Renal Replacement Therapy in ICU The Artificial Kidney Initiation in Kidney Injury trial AKIKI Stéphane Gaudry Réanimation médico-chirurgicale Hôpital Louis Mourier, Colombes
More informationCentral Nervous System Infection
Central Nervous System Infection Lingyun Shao Department of Infectious Diseases Huashan Hospital, Fudan University Definition Meningitis: an inflammation of the arachnoid membrane, the pia mater, and the
More informationCulture Proven Bacterial Meningitis in Children: Agents, Clinical Profile and Outcome
Culture Proven Bacterial Meningitis in Children: Agents, Clinical Profile and Outcome Ansari I, Pokhrel Y Department of Pediatrics Patan Academy of Health Sciences, Patan Hospital Lagankhel, Lalitpur;
More informationCubicin A Guide to Dosing
Cubicin A Guide to Dosing Cubicin (Daptomycin) powder for solution for injection or infusion Indications (see SmPC) 1 : Cubicin is indicated for the treatment of the following infections (see sections
More informationwithout the permission of the author Not to be copied and distributed to others
Emperor s Castle interior-prato What is the Role of Inhaled Polymyxins for Treatment of Respiratory Tract Infections? Helen Giamarellou CONCLUSIONS: Patients with Pseudomonas and Acinetobacter VAP may
More informationIMPACT #: Local Inventory #: form 04. Age at admission: d. mo yr. Postal code:
- Date of birth: birth: Date of admission: year month day year month day Age at admission: d mo yr Postal code: Ethnic code: Hospital: Gender: 1 = male 2 = female 1 = Impact 2 = Other local, specify: Code
More informationCopyright 2006 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins DOI: /01.CCM
Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study*
More informationGuidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age
Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age Nicole Le Saux; Canadian Paediatric Society Infectious Diseases and Immunization
More informationBacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B.
UvA-DARE (Digital Academic Repository) Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. Link to publication Citation for published version (APA): Heckenberg,
More informationCNS Infections. Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London. Hammersmith Acute Medicine 2011
CNS Infections Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London Hammersmith Acute Medicine 2011 Case 1 HISTORY 27y man Unwell 3 days Fever Headache Photophobia Previously
More informationMesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections
Ceftriaxone sodium Rapid onset, sustained action, for a broad spectrum of infections 1, 2, 3 Antibiotic with a broad spectrum of activity Broad spectrum of activity against gram-positive* and gram-negative
More informationClinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)
VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin
More informationTo develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.
Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment
More informationCLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel
CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe
More informationPharmacokinetics of daptomycin in a patient with severe renal failure not under dialysis
AAC Accepts, published online ahead of print on 1 April 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.00230-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Pharmacokinetics
More informationActivities of Ertapenem, a New Long-Acting Carbapenem, against Penicillin-Sensitive or -Resistant Pneumococci in Experimental Meningitis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2003, p. 1943 1947 Vol. 47, No. 6 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.6.1943 1947.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationContinuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook
Continuous Infusion of Antibiotics In The ICU: What Is Proven? Michael S. Niederman, M.D. Chairman, Department of Medicine Winthrop-University Hospital Mineola, NY Professor of Medicine Vice-Chairman,
More informationThe antibiotic dose and the obese ICU patient
The antibiotic dose and the obese ICU patient Philippe Montravers, M.D., Ph.D. Anaesthesia and Surgical ICU CHU Bichat Claude Bernard Assistance Publique-Hôpitaux de Paris INSERM UMR 1152 University Paris
More informationDevelopment of C sporins. Beta-lactam antibiotics - Cephalosporins. Second generation C sporins. Targets - PBP s
Beta-lactam antibiotics - Cephalosporins Development of C sporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability properties
More informationThe Value of C-Reactive Protein in Children with Meningitis
Helmy A. Qurtom, MRCP; Qusay A. Al-Salah, MRCP; Mahmoud M. Lubani, MD; Kamel I. Doudin, MD; Dinesh C. Sharda, FRCP; Areckal I. John, MD From the Department of Pediatrics, Farwania (Drs. Qurtom, Al-Saleh,
More informationClinical Features and Prognostic Factors in Adults with Bacterial Meningitis
original article Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis Diederik van de Beek, M.D., Ph.D., Jan de Gans, M.D., Ph.D., Lodewijk Spanjaard, M.D., Ph.D., Martijn Weisfelt,
More informationPneumococcal Meningitis Meningitis is an inflammation of the lining around the brain and spinal cord. Most severe cases
Pneumococcal Meningitis Meningitis is an inflammation of the lining around the brain and spinal cord. Most severe cases are caused by bacteria. Pneumococcal bacteria (Streptococcus pneumoniae) are the
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationTwice daily ceftriaxone therapy for serious bacterial infections in children
Journal of Antimicrobial Chemotherapy (1984) 13, 511-516 Twice daily ceftriaxone therapy for serious bacterial infections in children Tasnee Chonmaitree*, Blaise L. Congenif, Jose Munoz+, Tamara A. Rakusan*,
More informationThe CLSI Approach to Setting Breakpoints
The CLSI Approach to Setting Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic
More informationPenicillin- and Cephalosporin-Resistant Pneumococcal Meningitis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1994, p. 1320-1324 Vol. 38, No. 6 0066-4804/94/$04.00+0 Copyright C) 1994, American Society for Microbiology Effect of Dexamethasone on Therapy of Experimental
More informationEfficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae Strains in a rabbit meningitis model.
AAC Accepts, published online ahead of print on 3 September 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.00285-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 1 2 Efficacy
More informationManaging meningitis not just antibiotics. Helena White December 2013
Managing meningitis not just antibiotics Helena White December 2013 Case history 43 year old British-born Asian lady Legal advisor Married with a three year old child (on Amoxicillin for recent ear infection)
More informationAcute Bacterial Meningitis in Infants and Children Epidemiology and Management
REVIEW ARTICLE Pediatr Drugs 2011; 13 (6): 385-400 1174-5878/11/0006-0385/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Acute Bacterial Meningitis in Infants and Children Epidemiology
More informationEDUCATIONAL COMMENTARY VANCOMYCIN MONITORING
EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley
More informationCognitive outcome in adults with moderate disability after pneumococcal meningitis
Journal of Infection (2006) 52, 433 439 www.elsevierhealth.com/journals/jinf Cognitive outcome in adults with moderate disability after pneumococcal meningitis Martijn Weisfelt a, *, Diederik van de Beek
More informationSymptoms of meningism and raised numbers of cells in the CSF with a sterile bacterial culture.
Table 1. Definitions. Meningism Meningitis Sepsis Severe sepsis Septic shock Meningococcal sepsis Invasive meningococcal disease (IMD) Encephalitis Meningoencephalitis Aseptic Meningitis Symptoms associated
More informationVancomycin: Class: Antibiotic.
Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.
More informationGroup B streptococcal infection;. Bacteremia without a focus occurs in 80-85%,. July has been recognised as Group B Strep Awareness Month,.
Group B streptococcal infection;. Bacteremia without a focus occurs in 80-85%,. July has been recognised as Group B Strep Awareness Month,. 12-10-2017 Group B streptococci are uniformly sensitive to penicillin
More informationDilemmas in the Management of Meningitis & Encephalitis HEADACHE AND FEVER. What is the best initial approach for fever, headache, meningisums?
Dilemmas in the Management of Meningitis & Encephalitis Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine HEADACHE AND FEVER What is the best initial approach for fever,
More informationChoc septique. Frédéric Pène
Choc septique Frédéric Pène Réanimation Médicale, Hôpital Cochin, AP-HP Université Paris Descartes Institut Cochin, Inserm U1016, CNRS UMR-8104, Département 3i No conflict of interest A 54 y.o. male patient
More informationCURRENT GUIDELINES FOR SEPSIS MANAGEMENT
HELLENIC SEPSIS STUDY GROUP www.sepsis.gr CURRENT GUIDELINES FOR SEPSIS MANAGEMENT Evangelos J. Giamarellos-Bourboulis, MD, PhD Associate Professor of Medicine 4 th Department of Internal Medicine, National
More informationVancomycin Orion , Version 1.0. Public Summary of the Risk Management Plan
Vancomycin Orion 18.6.2015, Version 1.0 Public Summary of the Risk Management Plan VI.2 Elements for a Public Summary Vancomycin Orion is intravenously administered glycopeptide antibiotic. It is indicated
More informationLa farmacologia in aiuto
Ferrara, 15 giugno 2018 La farmacologia in aiuto Pier Giorgio Cojutti, Federico Pea Istituto di Farmacologia Clinica Azienda Sanitaria Universitaria Integrata di Udine Therapeutic Drug Monitoring of Beta-Lactams
More informationPHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS
PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS SITI HIR HURAIZAH MD TAHIR Bpharm (UKM), MSc (Clinical Microbiology) (UoN) CLINICAL PHARMACIST HOSPITAL MELAKA WHY STUDY PHARMACOKINETICS (PK) AND PHARMACODYNAMICS
More informationVancomycin Orion , Version 2 Public Summary of the Risk Management Plan
Vancomycin Orion 18.1.2016, Version 2 Public Summary of the Risk Management Plan VI.2 Elements for a Public Summary Vancomycin Orion is intravenously administered glycopeptide antibiotic. It is indicated
More informationCOPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED
The Transverse Myelitis Association...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)
More informationVANCOMYCIN DOSING AND MONITORING GUIDELINES
VANCOMYCIN DOSING AND MONITORING GUIDELINES NB Provincial Health Authorities Anti-Infective Stewardship Committee Approved: May 2017 GENERAL COMMENTS Vancomycin is a glycopeptide antibiotic with bactericidal
More informationI n Australia and the USA, where vaccination against
391 ORIGINAL ARTICLE A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis P B McIntyre, C R MacIntyre, R Gilmour, H
More informationFever Without a Source Age: 0-28 Day Pathway - Emergency Department Evidence Based Outcome Center
Age: 0-28 Day Pathway - Emergency Department EXCLUSION CRITERIA Toxic appearing No fever Born < 37 weeks gestational age INCLUSION CRITERIA Non-toxic with temperature > 38 C (100.4 F) < 36 C (96.5 F) measured
More informationAntibiotic Management of Pediatric Osteomyelitis
Reprinted from www.antimicrobe.org Sandra Arnold, M.D. Antibiotic Management of Pediatric Osteomyelitis Several points uncertainty exist regarding the antimicrobial management of acute hematogenous osteomyelitis,
More informationEndocardite infectieuse
Endocardite infectieuse 1. Raccourcir le traitement: jusqu où? 2. Proposer un traitement ambulatoire: à partir de quand? Endocardite infectieuse A B 90 P = 0.014 20 P = 0.0005 % infective endocarditis
More informationInitial Resuscitation of Sepsis & Septic Shock
Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known
More informationAciphin Ceftriaxone Sodium
Aciphin Ceftriaxone Sodium Only for the use of Medical Professionals Description Aciphin is a bactericidal, long-acting, broad spectrum, parenteral cephalosporin preparation, active against a wide range
More informationPersistence of Pneumolysin in the Cerebrospinal Fluid of Patients With Pneumococcal Meningitis Is Associated With Mortality
BRIEF REPORT Persistence of Pneumolysin in the Cerebrospinal Fluid of Patients With Pneumococcal Meningitis Is Associated With Mortality Emma C. Wall, 1,a Stephen B. Gordon, 1,a Samia Hussain, 2 Upali
More informationDepartment of Clinical Pharmacy, University of Michigan College of Pharmacy, Pharmacy Faculty, Siam University, Bangkok, Thailand
1 2 Article Type: Guest Ed Mistakes We Make in Dialysis 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 We underdose antibiotics in patients on CRRT Alexander R. Shaw Weerachai Chaijamorn Bruce A. Mueller 1 Ann
More informationBACTERIAL MENINGITIS: A FIVE YEAR ( ) RETROSPECTIVE STUDY AT UNIVERSITY MALAYA MEDICAL CENTer (UMMC), KUALA LUMPUR, MALAYSIA
BACTERIAL MENINGITIS: A FIVE YEAR (2001-2005) RETROSPECTIVE STUDY AT UNIVERSITY MALAYA MEDICAL CENTer (UMMC), KUALA LUMPUR, MALAYSIA H Erleena Nur, I Jamaiah, M Rohela and V Nissapatorn Department of Parasitology,
More informationFull title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control
Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes
More informationPharmacologyonline 3: (2009) ewsletter Singh et al.
USE OF CEFOPERAZO E - SULBACTAM 2:1 I PATIE TS WITH COMPROMISED RE AL FU CTIO Singh M*, Kochhar P*, Suvarna V*, Patel A** * Medical & Research Division, Pfizer India. ** Infectious Diseases Clinic, "VEDANTA"
More informationMulti-drug Resistant Serotype 19A Pneumococci in Toronto
TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant
More informationLessons from recent studies. João Gonçalves Pereira UCIP DALI
Lessons from recent studies João Gonçalves Pereira UCIP DALI 1 Patterns of Antimicrobial Activity Concentration C max Aminoglycosides Cmax/MIC>10 Metronidazol Area under the concentration curve Azithromycin
More informationContinuous vs Intermittent Dosing of Antibiotics in Critically-Ill Patients
Continuous vs Intermittent Dosing of Antibiotics in Critically-Ill Patients Jan O Friedrich, MD DPhil Associate Professor of Medicine, University of Toronto Medical Director, MSICU St. Michael s Hospital,
More informationCNS Infections. GBS Streptococcus agalactiae. Meningitis - Neonate
CNS Infections GBS Streptococcus agalactiae Bacterial meningitis - Pathophysiology - general Specific organisms - Age Hosts Treatment/Prevention Distinguish from viral disease Common commensal flora childbearing
More informationZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN
ZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN Anne Smits Fellow neonatologie UZ Leuven Use of antibiotics in neonates 50 European hospitals 23 non-european hospitals Countries n = 14 n = 9 Pediatric
More informationDaptomycin versus vancomycin in the treatment of methicillin-resistant. Staphylococcus aureus meningitis in experimental rabbit model.
AAC Accepts, published online ahead of print on 14 January 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01996-12 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Daptomycin
More informationIncidence per 100,000
Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background
More informationUvA-DARE (Digital Academic Repository) Pneumococcal meningitis in adults Weisfelt, M. Link to publication
UvA-DARE (Digital Academic Repository) Pneumococcal meningitis in adults Weisfelt, M. Link to publication Citation for published version (APA): Weisfelt, M. (2007). Pneumococcal meningitis in adults General
More informationAcute Bacterial Meningitis : Causative Organisms, Clinical Characteristics and Prognosis
Acute Bacterial Meningitis : Causative Organisms, Clinical Characteristics and Prognosis Dong-Chul Park, M.D., Il-Saing Choi, M.D., Ji-Hoe Heo, M.D., Kyoung-Won Lee, M.D.* Departments of Neurology and
More informationCNS Infections in the Pediatric Age Group
CNS Infections in the Pediatric Age Group Introduction CNS infections are frequently life-threatening In the Philippines, bacterial meningitis is one of the top leading causes of mortality in children
More informationAXITAB-CV TAB. COMPOSITION :
AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil
More informationDramatic reduction of mortality in pneumococcal meningitis
Buchholz et al. Critical Care (2016) 20:312 DOI 10.1186/s13054-016-1498-8 RESEARCH Open Access Dramatic reduction of mortality in pneumococcal meningitis Grete Buchholz 1, Uwe Koedel 1, Hans-Walter Pfister
More informationBrain abscess rupturing into the lateral ventricle causing meningitis: a case report
Brain abscess rupturing into the lateral ventricle causing meningitis: a case report Endry Martinez, and Judith Berger SBH Health System, 4422 Third Ave, Bronx, NY 10457 Key words: brain abscess, rupture
More informationCommunity-Acquired Bacterial Meningitis in Alcoholic Patients
Community-Acquired Bacterial Meningitis in Alcoholic Patients Martijn Weisfelt 1, Jan de Gans 2, Arie van der Ende 3, Diederik van de Beek 3 * 1 Department of Neurology, Kennemer Gasthuis, Haarlem, The
More informationTHE USE OF THE PENICILLINASE-RESISTANT
Therapeutic problems THE USE OF THE PENICILLINASE-RESISTANT PENICILLIN IN THE PNEUMONIAS OF CHILDREN MARTHA D. Yow, MARY A. SOUTH AND CHARLES G. HESS From the Department of Pediatrics, Baylor University
More informationObjectives. Pneumonia. Pneumonia. Epidemiology. Prevalence 1/7/2012. Community-Acquired Pneumonia in infants and children
Objectives Community-Acquired in infants and children Review of Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America - 2011 Sabah Charania,
More informationPK/PD degli antibiotici utilizzati nella sepsi
PK/PD degli antibiotici utilizzati nella sepsi Dario Cattaneo, U.O. Farmacologia Clinica ASST Fatebenefratelli Sacco, Milano Bergamo, città alta Variability of antibiotic concentrations in critically ill
More informationSepsi: nuove definizioni, approccio diagnostico e terapia
GIORNATA MONDIALE DELLA SEPSI DIAGNOSI E GESTIONE CLINICA DELLA SEPSI Giovedì, 13 settembre 2018 Sepsi: nuove definizioni, approccio diagnostico e terapia Nicola Petrosillo Società Italiana Terapia Antiinfettiva
More informationD DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2
Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following
More informationDepartment of Pharmacy Services, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA; 2
Pathogens 2015, 4, 599-605; doi:10.3390/pathogens4030599 Article OPEN ACCESS pathogens ISSN 2076-0817 www.mdpi.com/journal/pathogens Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for
More informationSuccessful treatment of pan - resistant pseudomonas Aerugınosa menıngıtıs wıth ıntrathecal polymyxın b therapy
ISPUB.COM The Internet Journal of Infectious Diseases Volume 7 Number 2 Successful treatment of pan - resistant pseudomonas Aerugınosa menıngıtıs wıth ıntrathecal polymyxın b F Simsek, T Yildirmak, G Cetmeli,
More informationMINIREVIEW. Management of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1995, p. 2171 2175 Vol. 39, No. 10 0066-4804/95/$04.00 0 Copyright 1995, American Society for Microbiology MINIREVIEW Management of Meningitis Caused by Penicillin-Resistant
More informationInvestigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017
January 2017 Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt Introduction Since the progressive introduction of meningococcal serogroup A conjugate vaccine (MACV) in the
More informationInvasive Pneumococcal Disease in Kanti Children s Hospital, Nepal, as Observed by the South Asian Pneumococcal Alliance Network
SUPPLEMENT ARTICLE Invasive Pneumococcal Disease in Kanti Children s Hospital, Nepal, as Observed by the South Asian Pneumococcal Alliance Network A. S. Shah, 1 M. Deloria Knoll, 2 P. R. Sharma, 1 J. C.
More informationA bs tr ac t. Background It is uncertain whether all adults with bacterial meningitis benefit from treatment with adjunctive dexamethasone.
The new england journal of medicine established in 1812 december 13, 2007 vol. 357 no. 24 Dexamethasone in Vietnamese Adolescents and Adults with Bacterial Meningitis Nguyen Thi Hoang Mai, M.D., Tran Thi
More informationKEY WORDS antibiotic treatment cerebrospinal fluid intraventricular antibiotic instillation pediatric neurosurgery shunt infection
J Neurosurg (3 Suppl Pediatrics) 107:213 219, 2007 Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization
More information